Ceres Nanosciences, Inc

Ceres Nanosciences Inc. (Ceres) is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap technology. The Nanotrap technology, coupled with existing research and clinical diagnostic platforms, improves the sensitivity and accuracy of a wide array of critical diagnostic processes. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs. Ceres currently sells the Nanotrap technology for use in a broad...

Clinical diagnostics,enhanced sample preparation,biomarker discovery and validation,and sample preservation

Ceres nanosciences, inc operates in the Biotechnology research industry.

Ceres nanosciences, inc's revenue is 11m - 100m

Ceres nanosciences, inc has 11 - 50 employees.